Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

  • L. Rasche
  • , S. S. Chavan
  • , O. W. Stephens
  • , P. H. Patel
  • , R. Tytarenko
  • , C. Ashby
  • , M. Bauer
  • , C. Stein
  • , S. Deshpande
  • , C. Wardell
  • , T. Buzder
  • , G. Molnar
  • , M. Zangari
  • , F. Van Rhee
  • , S. Thanendrarajan
  • , C. Schinke
  • , J. Epstein
  • , F. E. Davies
  • , B. A. Walker
  • , T. Meissner
  • B. Barlogie, G. J. Morgan, N. Weinhold

Research output: Contribution to journalArticlepeer-review

337 Scopus citations

Abstract

In multiple myeloma malignant plasma cells expand within the bone marrow. Since this site is well-perfused, a rapid dissemination of "fitter" clones may be anticipated. However, an imbalanced distribution of multiple myeloma is frequently observed in medical imaging. Here, we perform multi-region sequencing, including iliac crest and radiology-guided focal lesion specimens from 51 patients to gain insight into the spatial clonal architecture. We demonstrate spatial genomic heterogeneity in more than 75% of patients, including inactivation of CDKN2C and TP53, and mutations affecting mitogen-activated protein kinase genes. We show that the extent of spatial heterogeneity is positively associated with the size of biopsied focal lesions consistent with regional outgrowth of advanced clones. The results support a model for multiple myeloma progression with clonal sweeps in the early phase and regional evolution in advanced disease. We suggest that multi-region investigations are critical to understanding intra-patient heterogeneity and the evolutionary processes in multiple myeloma.

Original languageEnglish
Article number268
JournalNature Communications
Volume8
Issue number1
DOIs
StatePublished - 1 Dec 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing'. Together they form a unique fingerprint.

Cite this